Does what happens at YC stay at YC?
Community has never felt louder in startupland. Bringing people together over a shared interest is innate to human nature. And, coming out of a lonely, draining pandemic, every startup wants…
Community has never felt louder in startupland. Bringing people together over a shared interest is innate to human nature. And, coming out of a lonely, draining pandemic, every startup wants…
Motional, the $4 billion joint venture between Aptiv and Hyundai, is exploring the company’s potential involvement in autonomous trucking or logistics, its CEO said today during a live session at…
To get a roundup of TechCrunch’s biggest and most important stories delivered to your inbox every day at 3 p.m. PDT, subscribe here. Hello and welcome to Daily Crunch for…
“The threats posed by crypto show that congress and federal regulators can’t continue to hide out, hoping crypto will go away,” said the Massachusetts senator. Read MoreCointelegraph.com News
Guy Martin Contributor Share on Twitter Guy Martin is the executive director of OASIS Open, one of the most respected nonprofit standards organizations in the world. He brings more than…
Many of the highest-profile English tutoring platforms focus on children, including VIPKID and Magic Ears. Ringle created a niche for itself by focusing on adults first, with courses like business…
Abhinav Shashank Contributor Share on Twitter Innovaccer founder and CEO Abhinav Shashank has written more than 300 articles for various international media outlets and has also been listed in Forbes’…
Bitcoin is heating up — some may say erupting — as the Latin American country plans to tap energy from volcanoes for mining the cryptocurrency. Read MoreCointelegraph.com News
While electric vertical take-off and landing passenger aircraft startup Joby Aviation is targeting North America for its initial commercial launch, founder and CEO JoeBen Bevirt expects the company to have…
On Monday, a 17-year drought in the world of Alzheimer’s drugs ended with the FDA approval of Biogen’s Aduhlem (aducanumab). The controversy behind the FDA’s decision was considerable, but it…